JPH0678325B2 - Process for producing sphingosine derivative, intermediate and process for producing the same - Google Patents
Process for producing sphingosine derivative, intermediate and process for producing the sameInfo
- Publication number
- JPH0678325B2 JPH0678325B2 JP63265862A JP26586288A JPH0678325B2 JP H0678325 B2 JPH0678325 B2 JP H0678325B2 JP 63265862 A JP63265862 A JP 63265862A JP 26586288 A JP26586288 A JP 26586288A JP H0678325 B2 JPH0678325 B2 JP H0678325B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- aldehyde
- producing
- general formula
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Description
【発明の詳細な説明】 本発明はスフィンゴシン誘導体の製造方法及び中間体と
その製造法に関する。詳しくは一般式(I)で示される
中間体とこれを一般式(II)で示 (R及びR″は置換された、または非置換のアルキル
基,アルケニル基、アルキニル基、アリール基、アラル
キル基を、R′はアミノ保護基を示す。) されるホスホン酸エステル誘導体から製造し、次いで中
間体(I)を還元する、一般式(III)で示されるスフ
ィンゴシン誘導体の製造方法に関する。The present invention relates to a method for producing a sphingosine derivative, an intermediate and a method for producing the same. Specifically, the intermediate represented by the general formula (I) and the intermediate represented by the general formula (II) (R and R ″ represent a substituted or unsubstituted alkyl group, alkenyl group, alkynyl group, aryl group and aralkyl group, and R ′ represents an amino-protecting group.), Then, it relates to a method for producing a sphingosine derivative represented by the general formula (III), in which the intermediate (I) is reduced.
(Rは置換された、または非置換のアルキル基,アルケ
ニル基、アルキニル基、アリール基、アラルキル基を、
R′はアミノ保護基を示す。) スフィンゴシンはスフィンゴ糖脂質の必須構造である。
スフィンゴ糖脂質は最近生体内で重要な働きを担ってい
ることが明らかになってきている。例えばガングリオシ
ドGQ1bと呼ばれるスフィンゴ糖脂質は神経細胞の分化と
深く係わっていることが報告されている。しかしながら
これらスフィンゴ糖脂質は天然からは極めて微量しか得
られずこれを医薬として利用するためにはその合成法の
開発が不可欠で既に種々のスフィンゴシンの合成が報告
されている。[D.Shapiro,“Chemistry of Sphingolipi
ds";Hermann:Paris,France,1969;H.Newmann,J.Am.Chem.
Soc.,95,4098(1973);R.S.Garigipati and S.M.Weinre
b,ibid.,105,4499(1983);M.A.Findeis and G.M. Whit
esides,J.Org.Chem.,52,2838(1987);K.Koike,M.Numat
a,and T.Ogawa,Carbohydr.Res.,158,113(1986);M.Kis
o,A.Nakamura,Y.Tomita,and A.Hasegawa,ibid.,158,101
(1986).参照] これらの合成法では立体異性体や幾何異性体の混入が著
しく、特にオレフィン部分の合成では(E)−オレフィ
ン体と(Z)−オレフィン体の混合物が得られるため工
業的に優れた方法とは言い難い。 (R is a substituted or unsubstituted alkyl group, alkenyl group, alkynyl group, aryl group, aralkyl group,
R'represents an amino protecting group. ) Sphingosine is an essential structure of glycosphingolipids.
Recently, it has become clear that glycosphingolipids have important functions in the living body. For example, it has been reported that a glycosphingolipid called ganglioside GQ1b is deeply involved in the differentiation of nerve cells. However, very small amounts of these glycosphingolipids are obtained from nature, and development of a synthetic method thereof is indispensable for utilizing them as medicines, and synthesis of various sphingosines has already been reported. [D.Shapiro, “Chemistry of Sphingolipi
ds "; Hermann: Paris, France, 1969; H. Newmann, J. Am. Chem.
Soc., 95, 4098 (1973); RS Garigipati and SMWeinre
b, ibid., 105,4499 (1983); MAFindeis and GM Whit
esides, J.Org.Chem., 52,2838 (1987); K.Koike, M.Numat
a, and T.Ogawa, Carbohydr.Res., 158,113 (1986); M.Kis
o, A.Nakamura, Y.Tomita, and A.Hasegawa, ibid., 158,101
(1986). Reference] In these synthetic methods, stereoisomers and geometrical isomers are significantly mixed, and particularly in the synthesis of the olefin part, a mixture of (E) -olefin and (Z) -olefin is obtained, which is an industrially excellent method. It is hard to say.
一方、スフィンゴ糖脂質を医薬等として実用化する場合
には、これらの類縁体の合成が必須である。しかしなが
ら従来の合成法でスフィンゴシンの異性体を製造しよう
とすれば各異性体に対し各々別の原料が必要である。On the other hand, when the glycosphingolipid is put to practical use as a medicine or the like, it is essential to synthesize these analogs. However, in order to produce isomers of sphingosine by the conventional synthetic method, different raw materials are required for each isomer.
本発明者らは上記の観点から鋭意研究した結果、特定の
中間体を経由すれば目的を達し得ることを知り本発明に
到達した。As a result of earnest research from the above viewpoints, the present inventors have found that the objective can be achieved via a specific intermediate, and have reached the present invention.
すなわち本発明の要旨は一般式(II)で示されるホスホ
ン酸エステル誘導体と置換された、または非置換のアル
キルアルデヒド、アルケニルアルデヒド、アルキニルア
ルデヒド、アリールアルデヒド、アラルキルアルデヒド
から選ばれるアルデヒドを塩基存在下に反応させ、得ら
れる一般式(I)で示される中間体とその工程、及び中
間体(I)を還元させ一般式(III)で示されるスフィ
ンゴシン誘導体の製造方法である。That is, the gist of the present invention is to provide an aldehyde selected from alkyl aldehydes, alkenyl aldehydes, alkynyl aldehydes, aryl aldehydes, and aralkyl aldehydes substituted or unsubstituted with the phosphonate derivative represented by the general formula (II) in the presence of a base. It is a method for producing the sphingosine derivative represented by the general formula (III) by reducing the intermediate (I) obtained by reacting the resulting intermediate represented by the general formula (I).
以下、本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
まず、一般式(I)で示される中間体の製造方法につい
て述べる。First, a method for producing the intermediate represented by the general formula (I) will be described.
原料となる一般式(II)で示されるホスホン酸エステル
誘導体はN−保護−N,OO−イソプロピリデンセリンエス
テルとメチルホスホン酸ジエステルとから常法により合
成することができる。The phosphonate derivative represented by the general formula (II) as a raw material can be synthesized from N-protected-N, OO-isopropylidene serine ester and methylphosphonate diester by a conventional method.
N−保護−N,O−イソプロピリデンセリンエステルとし
ては周知の誘導体を使用できる。具体的には対応するメ
チルエステル、エチルエステル、ベンジルエステル等を
挙げることができる。また、アミノ保護基としては第3
ブチルオキシカルボニル(Boc)基、ベンジルオキシカ
ルボニル基、p−メトキシベンジルオキシカルボニル基
等の周知の保護基を使用できる。セリンにはL−体、D
−体が存在するが、そのいずれをも、あるいはこれらの
混合物が使用できることは言うまでもない。Well-known derivatives can be used as the N-protected-N, O-isopropylidene serine ester. Specific examples include corresponding methyl ester, ethyl ester, benzyl ester and the like. Also, the third amino protecting group is
Well-known protecting groups such as butyloxycarbonyl (Boc) group, benzyloxycarbonyl group and p-methoxybenzyloxycarbonyl group can be used. Serine is L-form, D
It goes without saying that there are bodies, any of which or mixtures thereof can be used.
メチルホスホン酸エステルも周知の誘導体を使用でき
る。具体的にはジメチルエステル、ジエチルエステル、
ジフェニルエステル、ジベンジルエステル等を挙げるこ
とができる。Well-known derivatives of methylphosphonate can also be used. Specifically, dimethyl ester, diethyl ester,
Examples thereof include diphenyl ester and dibenzyl ester.
他の原料となるアルデヒドとしては周知のものを使用で
きる。すなわち、脂肪族アルデヒド、芳香族アルデヒド
のいずれをも使用できる。具体的には、脂肪族アルデヒ
ドとして、ホルムアルデヒド、アセトアルデヒド、プロ
ピルアルデヒド、ブチルアルデヒド、ペンチルアルデヒ
ド、デシルアルデヒド、トリデシルアルデヒド、テトラ
デシルアルデヒド、ペンタデシルアルデヒド、ヘキサデ
シルアルデヒド等を挙げることが出来る。また、芳香族
アルデヒドとしては、ベンズアルデヒド、ベンジルアル
デヒド、フェニルエチルアルデヒド等を挙げることが出
来る。また、これらアルデヒドに他の官能基が含まれて
いても使用できることは言うまでもない。Well-known aldehydes can be used as other raw materials. That is, either an aliphatic aldehyde or an aromatic aldehyde can be used. Specific examples of the aliphatic aldehyde include formaldehyde, acetaldehyde, propyl aldehyde, butyraldehyde, pentyl aldehyde, decyl aldehyde, tridecyl aldehyde, tetradecyl aldehyde, pentadecyl aldehyde and hexadecyl aldehyde. Examples of aromatic aldehydes include benzaldehyde, benzyl aldehyde, phenylethyl aldehyde and the like. Needless to say, these aldehydes can be used even if they contain other functional groups.
用いる溶媒としては特に制限はない。具体的にはメタノ
ール、イソプロピルアルコール、ジエチルエーテル、ベ
ンゼン、トルエン、テトラヒドロフラン、ジクロロメタ
ン、ジオキサン、クロロホルム等を挙げることができ
る。特にアルコール系溶媒とりわけイソプロピルアルコ
ールが好ましい。The solvent used is not particularly limited. Specific examples include methanol, isopropyl alcohol, diethyl ether, benzene, toluene, tetrahydrofuran, dichloromethane, dioxane and chloroform. Alcohol solvents, especially isopropyl alcohol, are particularly preferable.
用いる塩基としては周知の塩基を使用できる。例えば水
素化ナトリウム、トリエチルアミン、水酸化ナトリウ
ム、炭酸カリウム、炭酸セシウム、ブチルリチウム等を
挙げることが出来る。これらの中でも特に炭酸塩とりわ
け炭酸セシウムが有効である。Well-known bases can be used as the base to be used. For example, sodium hydride, triethylamine, sodium hydroxide, potassium carbonate, cesium carbonate, butyl lithium and the like can be mentioned. Of these, carbonates, especially cesium carbonate, are particularly effective.
反応させる際、一般式(II)で示されるホスホン酸エス
テル誘導体とアルデヒド及び塩基のモル比には特に制限
がない。しかし、通常それぞれ等モルあるいはアルデヒ
ドを1.1〜1.3等量使用する。またホスホン酸エステル誘
導体やアルデヒドを過剰に用いてもあるいは各々大過剰
使用できることは言うまでもない。In the reaction, the molar ratio of the phosphonate derivative represented by the general formula (II) to the aldehyde and the base is not particularly limited. However, usually equimolar amounts or 1.1 to 1.3 equivalents of aldehyde are used, respectively. Needless to say, the phosphonate derivative or the aldehyde can be used in excess or in large excess.
反応温度にも特に制限はないが、通常−100℃〜60℃の
範囲である。特に−80℃〜30℃の範囲が好ましい。反応
時間は数時間から数十時間の範囲である。The reaction temperature is not particularly limited, but is usually in the range of -100 ° C to 60 ° C. Particularly, the range of -80 ° C to 30 ° C is preferable. The reaction time is in the range of several hours to several tens of hours.
以上の様に合成した中間体(I)はいずれも(E)−オ
レフィン体で従来法のように(Z)−オレフィン体の混
入は認められなかった。All of the intermediates (I) synthesized as described above were (E) -olefins, and no contamination of (Z) -olefins was observed as in the conventional method.
次に一般式(III)で示されるスフィンゴシン誘導体の
製造方法について述べる。Next, a method for producing the sphingosine derivative represented by the general formula (III) will be described.
上述した様に合成した一般式(I)で示される中間体の
カルボニル基を周知の還元剤で還元すればスフィンゴシ
ン誘導体(III)が得られる。還元剤としては周知の還
元剤を使用できる。具体的には水素化ホウ素ナトリウ
ム、水素化トリ第2ブチルホウ素リチウム、水素化トリ
第2ブチルホウ素ナトリウム、水素化ジイソブチルアル
ミニウム、9−ボラビシクロ[3.3.1]ノナン等を挙げ
ることが出来る。また、立体選択性を高める等のため臭
化亜鉛、臭化マグネシウム、塩化セリウム等の添加物を
共存させることもできる。The sphingosine derivative (III) can be obtained by reducing the carbonyl group of the intermediate represented by the general formula (I) synthesized as described above with a known reducing agent. Well-known reducing agents can be used as the reducing agent. Specific examples include sodium borohydride, lithium tri-tert-butylborohydride, sodium tri-tert-butylborohydride, diisobutylaluminum hydride, 9-borabicyclo [3.3.1] nonane, and the like. In addition, additives such as zinc bromide, magnesium bromide and cerium chloride can be made to coexist in order to enhance stereoselectivity.
用いる溶媒としては特に制限がない。具体的には前述し
た有機溶媒を使用できる。特にこれらの中でテトラヒド
ロフラン及びテトラヒドロフランとアルコール系溶媒と
の混合溶媒が有効である。The solvent used is not particularly limited. Specifically, the above-mentioned organic solvent can be used. Of these, tetrahydrofuran and a mixed solvent of tetrahydrofuran and an alcohol solvent are particularly effective.
反応させる還元剤のモル比は特に制限がない。しかし通
常はカルボニル基に対し1.0〜10等量の範囲である。There is no particular limitation on the molar ratio of the reducing agent to be reacted. However, it is usually in the range of 1.0 to 10 equivalents with respect to the carbonyl group.
反応温度にも特に制限はないが通常−100℃〜50℃の範
囲である。The reaction temperature is not particularly limited, but is usually in the range of -100 ° C to 50 ° C.
上記還元反応と原料を組み合わせることにより好ましい
立体異性体の製造をも可能にしている。By combining the above reduction reaction and the raw materials, it is possible to produce a preferable stereoisomer.
以上述べたように合成したスフィンゴシン誘導体(II
I)を常法により脱保護すると、スフィンゴシンに誘導
できる。この脱保護に関しては既に知られている。[P.
Garner,J.M.Park,and E.Malecki,J.Org.Chem.,53,4395
(1988).参照] このように本発明方法はセリンの誘導体から一般式
(I)で示される中間体を経由し、スフィンゴシン誘導
体として知られる一般式(III)で示される化合物を収
率良くまた立体異性体や幾何異性体の混入もほとんどな
く製造できるという利点を有しており加えて立体異性体
を作り分けることも可能で、その工業的価値は大であ
る。以下、実施例等を挙げて本発明をさらに詳細に説明
するが本発明はその要旨を越えない限り、以下の実施例
等により何等の制限を受けるものではない。The sphingosine derivative synthesized as described above (II
Deprotection of I) by a conventional method can induce sphingosine. This deprotection is already known. [P.
Garner, JMPark, and E.Malecki, J.Org.Chem., 53,4395
(1988). Reference] As described above, in the method of the present invention, a compound represented by the general formula (III) known as a sphingosine derivative is obtained from a derivative of serine via an intermediate represented by the general formula (I) in good yield and stereoisomers and It has an advantage that it can be produced with almost no mixing of geometrical isomers, and in addition, stereoisomers can be produced separately, and its industrial value is great. Hereinafter, the present invention will be described in more detail with reference to Examples and the like, but the present invention is not limited by the following Examples and the like as long as the gist thereof is not exceeded.
参考例 1 メチルホスホン酸ジメチル1.49g(12mmol)をテトラヒ
ドロフラン40mlに溶解させ、−78℃に冷却し、これに1.
57Mブチルリチウム/ヘキサン溶液を7.7ml滴下した。次
いでN−Boc−N,O−イソプロピリデン−L−セリンメチ
ルエステル2.59g(10mmol)を加えた。反応温度を一夜
かけて室温まであげ、常法により酢酸エチルで抽出し
た。溶媒を減圧留去しシリカゲルカラムクロマトにより
精製したところN−Boc−N,O−イソプロピリデン−L−
セリルメチルホスホン酸ジメチルが油状物質として1.93
g(55%)得られた。1H NMR(CDCl3)δ1.45(9H,s),
1.51(3H,s),1.65(3H,s),3.33(2H,dd,J=9,22Hz),
3.80(6H,d,J=11Hz)。Reference Example 1 1.49 g (12 mmol) of dimethyl methylphosphonate was dissolved in 40 ml of tetrahydrofuran and cooled to −78 ° C., and 1.
7.7 ml of 57M butyllithium / hexane solution was added dropwise. Then 2.59 g (10 mmol) of N-Boc-N, O-isopropylidene-L-serine methyl ester was added. The reaction temperature was raised to room temperature overnight, and the mixture was extracted with ethyl acetate by a conventional method. The solvent was distilled off under reduced pressure and the residue was purified by silica gel column chromatography to obtain N-Boc-N, O-isopropylidene-L-
Dimethyl cerylmethylphosphonate 1.93 as an oil
g (55%) was obtained. 1 H NMR (CDCl 3 ) δ 1.45 (9H, s),
1.51 (3H, s), 1.65 (3H, s), 3.33 (2H, dd, J = 9,22Hz),
3.80 (6H, d, J = 11Hz).
実施例 1 氷冷下、参考例1で合成したホスホン酸エステル0.73g
(2.1mmol)と炭酸セシウム0.78g(2.4mmol)をイソプ
ロピルアルコール9mlに懸濁させ、これにテトラデシル
アルデヒド0.67g(3.2mmol)を加え一夜室温で反応させ
た。常法により酢酸エチルで抽出し、カラムクロマトで
精製したところ目的とするオレフィン体が0.79g(86
%)得られた。13C NMR(CDCl3)δ14.1,22.7,24.3,25.
3,26.1,27.5,28.1,28.3,29.2,29.4,29.6,32.0,32.7,33.
8,64.1,64.8,65.8,80.5,95.1,125.6,149.4,151.6,196.
3。Example 1 0.73 g of phosphonate synthesized in Reference Example 1 under ice cooling
(2.1 mmol) and cesium carbonate 0.78 g (2.4 mmol) were suspended in isopropyl alcohol 9 ml, and tetradecyl aldehyde 0.67 g (3.2 mmol) was added thereto and reacted overnight at room temperature. After extraction with ethyl acetate by a conventional method and purification by column chromatography, 0.79 g (86
%) Obtained. 13 C NMR (CDCl 3 ) δ 14.1, 22.7, 24.3, 25.
3,26.1,27.5,28.1,28.3,29.2,29.4,29.6,32.0,32.7,33.
8,64.1,64.8,65.8,80.5,95.1,125.6,149.4,151.6,196.
3.
実施例 2 実施例1で合成したオレフィン体56.5mg(0.13mmol)を
0.4M塩化セリウム/テトラヒドロフラン−メタノール
(2:1)溶液0.33mlに溶解させた。これに水素化ホウ素
ナトリウム5mg(0.13mmol)を室温で加えた。5分後5
%クエン酸溶液で反応を停止させ、常法によりエーテル
で抽出し、シリカゲルカラムクロマトで精製したとこ
ろ、N−Boc−N,O−イソプロピリデン−D−erythro−C
18−スフィンゴシンがそのthreo体との混合物として92
%得られた。13C NMRより求めた異性対比は5:1でerythr
o体が優先していた。13C NMR(CDCl3)δ135.2(thre
o),133.4(erythro)。Example 2 56.5 mg (0.13 mmol) of the olefin compound synthesized in Example 1
It was dissolved in 0.33 ml of 0.4 M cerium chloride / tetrahydrofuran-methanol (2: 1) solution. To this was added sodium borohydride 5 mg (0.13 mmol) at room temperature. 5 minutes later 5
%, The reaction was stopped with a citric acid solution, extraction with ether was carried out by a conventional method, and purification by silica gel column chromatography revealed that N-Boc-N, O-isopropylidene-D-erythro-C.
18-sphingosine as a mixture with its threo body 92
% Obtained. The isomer ratio determined by 13 C NMR was 5: 1 and erythr.
o My body was my priority. 13 C NMR (CDCl 3 ) δ135.2 (thre
o), 133.4 (erythro).
実施例 3 実施例1で合成したオレフィン体131.2mg(0.3mmol)を
テトラヒドロフラン4mlに溶解させ、−78℃で1.1M水素
化トリ第2ブチルホウ素リチウム/テトラヒドロフラン
溶液0.33ml(0.36mmol)を滴下した。反応温度を一夜か
けて室温まであげ、常法により抽出し実施例2と同様に
精製したところ、収率90%異性対比3:1でthreo体が優先
した。Example 3 131.2 mg (0.3 mmol) of the olefin compound synthesized in Example 1 was dissolved in 4 ml of tetrahydrofuran, and 0.33 ml (0.36 mmol) of a 1.1 M lithium tri-tert-butylborohydride / tetrahydrofuran solution was added dropwise at -78 ° C. . The reaction temperature was raised to room temperature overnight, and the mixture was extracted by a conventional method and purified in the same manner as in Example 2. The yield was 90%, and the threo form was preferential with a isomer ratio of 3: 1.
Claims (5)
成中間体。 (Rは置換された、または非置換のアルキル基,アルケ
ニル基、アルキニル基、アリール基、アラルキル基を、
R′はアミノ保護基を示す。)1. A sphingosine synthetic intermediate represented by the general formula (I). (R is a substituted or unsubstituted alkyl group, alkenyl group, alkynyl group, aryl group, aralkyl group,
R'represents an amino protecting group. )
オキシカルボニル基である事を特徴とする特許請求の範
囲第1項記載の中間体。2. The intermediate according to claim 1, wherein the amino protecting group represented by R'is a tert-butyloxycarbonyl group.
ル誘導体と、置換された、または非置換のアルキルアル
デヒド、アルケニルアルデヒド、アルキニルアルデヒ
ド、アリールアルデヒド、アラルキルアルデヒドから選
ばれるアルデヒドを塩基存在下に反応させることを特徴
とする特許請求の範囲第1項記載の中間体の製造方法。 (RおよびR″は置換された、または非置換のアルキル
基,アルケニル基、アルキニル基、アリール基、アラル
キル基を、R′はアミノ保護基を示す。)3. A phosphonate derivative represented by the general formula (II) and an aldehyde selected from a substituted or unsubstituted alkyl aldehyde, alkenyl aldehyde, alkynyl aldehyde, aryl aldehyde and aralkyl aldehyde in the presence of a base. The method for producing an intermediate according to claim 1, wherein the intermediate is reacted. (R and R ″ represent a substituted or unsubstituted alkyl group, alkenyl group, alkynyl group, aryl group and aralkyl group, and R ′ represents an amino protecting group.)
徴とする特許請求の範囲第3項記載の製造方法。4. The method according to claim 3, wherein cesium carbonate is used as the base.
ステル誘導体から特許請求の範囲第1項記載の中間体と
し、これを還元する事を特徴とする一般式(III)で示
されるスフィンゴシン誘導体の製造方法。 (Rは置換された、または非置換のアルキル基,アルケ
ニル基、アルキニル基、アリール基、アラルキル基を、
R′はアミノ保護基を示す。)5. A sphingosine represented by the general formula (III), characterized by reducing the phosphonate derivative according to claim 3 to the intermediate according to claim 1 and reducing the intermediate. Method for producing derivative. (R is a substituted or unsubstituted alkyl group, alkenyl group, alkynyl group, aryl group, aralkyl group,
R'represents an amino protecting group. )
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63265862A JPH0678325B2 (en) | 1988-10-21 | 1988-10-21 | Process for producing sphingosine derivative, intermediate and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63265862A JPH0678325B2 (en) | 1988-10-21 | 1988-10-21 | Process for producing sphingosine derivative, intermediate and process for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02115177A JPH02115177A (en) | 1990-04-27 |
| JPH0678325B2 true JPH0678325B2 (en) | 1994-10-05 |
Family
ID=17423120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63265862A Expired - Fee Related JPH0678325B2 (en) | 1988-10-21 | 1988-10-21 | Process for producing sphingosine derivative, intermediate and process for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0678325B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100349187B1 (en) * | 1999-12-24 | 2002-08-14 | 학교법인 포항공과대학교 | Manufacturing method for derivatives of sphingosine and sphinganine |
-
1988
- 1988-10-21 JP JP63265862A patent/JPH0678325B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02115177A (en) | 1990-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4151172A (en) | Phosphonoacyl prolines and related compounds | |
| Suzuki et al. | The enantioselective Michael addition of thiols to cycloalkenones by using (2S, 4S)-2-anilinomethyl-1-ethyl-4-hydroxypyrrolidine as chiral catalyst. | |
| Avenoza et al. | Enantioselective synthesis of (S)-and (R)-α-methylserines: application to the synthesis of (S)-and (R)-N-Boc-N, O-isopropylidene-α-methylserinals | |
| KR100926844B1 (en) | A process for the synthesis of sphingosine | |
| CN101641364B (en) | Phosphoroamide compound, method for producing the same, ligand, complex, catalyst, and method for producing optically active alcohol | |
| KR970011164B1 (en) | Method for preparing unsaturated amino acid compound | |
| JPH0678325B2 (en) | Process for producing sphingosine derivative, intermediate and process for producing the same | |
| EP2751124B1 (en) | Versatile and stereospecific synthesis of gamma,delta -unsaturated amino acids by wittig reaction | |
| EP0336123A2 (en) | New chiral phosphinopyrrolidine compounds and their use for asymmetric synthesis of optically active compounds | |
| JP4143787B2 (en) | Method for producing α-aminohalomethyl ketone derivative | |
| JPH10245369A (en) | Production of serine derivative | |
| JP2562782B2 (en) | Method for producing triol derivative | |
| US20040143143A1 (en) | Preparation and use of diols | |
| Fielden et al. | Design and sterospecific synthesis of modular ligands based upon cis-1, 3-trans-5-substituted cyclohexanes | |
| JP2673478B2 (en) | Ceramide derivative, its production method and intermediate | |
| JP2022126890A (en) | Fluoroalkyl group-containing compound and method for producing the same | |
| JPH05194568A (en) | New homochiral diphosphines | |
| JP5004119B2 (en) | 2-phthalimido-3-phosphonopropionic acid ester compound and method for producing the same | |
| JPH0662602B2 (en) | Triol derivative and its production method | |
| Lebedev et al. | Pd-catalyzed asymmetric allylation of an o-carborane derivative | |
| HU207711B (en) | Process for producing glutaric acid derivatives | |
| JP2848937B2 (en) | Process for producing substituted methylenecyclopentanes | |
| JPH0859576A (en) | Method for producing optically active aminoketone and aminoalcohol | |
| JP3770678B2 (en) | Optically active alcohol and its carboxylic acid ester | |
| JP2005104895A (en) | Method for preparing optically active amino alcohol compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |